Autres langues Haemonetics Corporation

Actions

HAE

US4050241003

Equipement, fournitures et distribution médicale

Marché Fermé - NYSE 22:00:25 17/09/2026			Varia. 5j.	Varia. 1 janv.
107,60 ^USD	+1,28%		+6,47%	+34,25%

17/09	L'action Haemonetics progresse après un relèvement de recommandation par Citigroup	MT
17/09	Haemonetics Corporation : Citigroup désormais positif sur le dossier	ZM

Autres langues

17/09	Haemonetics Shares Rise After Citigroup Upgrade
15/09	Orchestra BioMed Obtains $6.1 Million Milestone Payment From Haemonetics' Acquisition of Vivasure
18/08	Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma
06/08	Haemonetics Corporation Reports Earnings Results for the First Quarter Ended June 27, 2026
06/08	Haemonetics' Fiscal Q1 Adjusted Earnings, Net Revenue Increase; Fiscal 2027 Outlook Raised
06/08	Earnings Flash (HAE) Haemonetics Posts Fiscal Q1 Adjusted EPS $1.14, vs. FactSet Est of $0.87
06/08	Earnings Flash (HAE) Haemonetics Posts Fiscal Q1 Net Revenue $339.4M, vs. FactSet Est of $327.9M
06/08	Haemonetics: Fiscal Q1 Earnings Snapshot
06/08	Haemonetics : First Quarter Fiscal 2027 Earnings Release
06/08	Tranche Update on Haemonetics Corporation's Equity Buyback Plan announced on May 8, 2025.
06/08	Haemonetics : Q1 2027 Haemonetics Corporation Earnings Release
06/08	Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website
03/08	New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
03/08	Haemonetics Corporation Publishes Study Demonstrating Safety And Efficacy Of VASCADE MVP XL Venous Vascular Closure System In Large-Bore Sheath Electrophysiology Procedures
28/07	Martin Madaus Elected to Haemonetics Board of Directors
28/07	Haemonetics Corporation Announces the Election of Martin Madaus to Board of Directors, Effective July 24, 2026
08/07	Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026
29/06	Haemonetics Corporation(NYSE:HAE) added to Russell 2000 Value Benchmark
29/06	Haemonetics Corporation(NYSE:HAE) added to Russell 2000 Value-Defensive Index
29/06	Haemonetics Corporation(NYSE:HAE) added to Russell 3000E Value Benchmark
29/06	Haemonetics Corporation(NYSE:HAE) added to Russell 3000 Value Benchmark
29/06	Haemonetics Corporation(NYSE:HAE) added to Russell Small Cap Comp Value Benchmark
29/06	Haemonetics Corporation(NYSE:HAE) added to Russell 2500 Value Benchmark
05/06	Haemonetics Narrows Reporting Structure
05/06	Haemonetics Updates Financial Reporting Segments